Literature DB >> 11796386

Characterization of mutations in DNA gyrase and topoisomerase IV Involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro.

A K Reinhardt1, C M Bébéar, M Kobisch, I Kempf, A V Gautier-Bouchardon.   

Abstract

Mycoplasma gallisepticum enrofloxacin-resistant mutants were generated by stepwise selection in increasing concentrations of enrofloxacin. Alterations were found in the quinolone resistance-determining regions of the four target genes encoding DNA gyrase and topoisomerase IV from these mutants. This is the first description of such mutations in an animal mycoplasma species.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11796386      PMCID： PMC127038          DOI： 10.1128/AAC.46.2.590-593.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  The polymerase chain reaction for Mycoplasma gallisepticum detection.

Authors:  I Kempf; A Blanchard; F Gesbert; M Guittet; G Bennejean
Journal:  Avian Pathol       Date:  1993-12       Impact factor: 3.378

2.  Characterization of genes encoding topoisomerase IV of Mycoplasma genitalium.

Authors:  C C Bailey; R Younkins; W M Huang; K F Bott
Journal:  Gene       Date:  1996-02-02       Impact factor: 3.688

3.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.

Authors:  R Himmelreich; H Hilbert; H Plagens; E Pirkl; B C Li; R Herrmann
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

4.  In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.

Authors:  C M Bebear; H Renaudin; A Charron; D Gruson; M Lefrancois; C Bebear
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.

Authors:  C M Bebear; J Renaudin; A Charron; H Renaudin; B de Barbeyrac; T Schaeverbeke; C Bebear
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene.

Authors:  J Tankovic; F Mahjoubi; P Courvalin; J Duval; R Leclerco
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  Effects of Baytril, Tylosin and Tiamulin on avian mycoplasmas.

Authors:  F T Jordan; S Gilbert; D L Knight; C A Yavari
Journal:  Avian Pathol       Date:  1989-10       Impact factor: 3.378

8.  Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.

Authors:  L Ferrero; B Cameron; B Manse; D Lagneaux; J Crouzet; A Famechon; F Blanche
Journal:  Mol Microbiol       Date:  1994-08       Impact factor: 3.501

9.  Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; L M Yamanaka; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

10.  Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.

Authors:  H Ito; H Yoshida; M Bogaki-Shonai; T Niga; H Hattori; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191
View more
  11 in total

1.  DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.

Authors:  C M Bébéar; H Renaudin; A Charron; M Clerc; S Pereyre; C Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

2.  Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene.

Authors:  J Le Carrou; M Laurentie; M Kobisch; A V Gautier-Bouchardon
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis.

Authors:  I Lysnyansky; I Mikula; I Gerchman; S Levisohn
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

4.  Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.

Authors:  I Lysnyansky; I Gerchman; I Mikula; F Gobbo; S Catania; S Levisohn
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

5.  Alterations in the Quinolone Resistance-Determining Regions and Fluoroquinolone Resistance in Clinical Isolates and Laboratory-Derived Mutants of Mycoplasma bovis: Not All Genotypes May Be Equal.

Authors:  Dima Khalil; Claire A M Becker; Florence Tardy
Journal:  Appl Environ Microbiol       Date:  2015-12-04       Impact factor: 4.792

6.  Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.

Authors:  Nan Zhang; Xiaomei Ye; Yuzhi Wu; Zilong Huang; Xiaoyan Gu; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 7.  Antimicrobial Resistance in Bacterial Poultry Pathogens: A Review.

Authors:  Nguyen Thi Nhung; Niwat Chansiripornchai; Juan J Carrique-Mas
Journal:  Front Vet Sci       Date:  2017-08-10

8.  The PK-PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model.

Authors:  Nan Zhang; Yuzhi Wu; Zilong Huang; Lihua Yao; Longfei Zhang; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  Front Microbiol       Date:  2017-05-30       Impact factor: 5.640

9.  Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model.

Authors:  Nan Zhang; Yuzhi Wu; Zilong Huang; Chuanzhen Zhang; Longfei Zhang; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

10.  Antibiotic resistance of Mycoplasma Synoviae strains isolated in China from 2016 to 2019.

Authors:  Xiaorong Zhang; Mengjiao Guo; Di Xie; Yang Chen; Chengcheng Zhang; Yongzhong Cao; Yantao Wu
Journal:  BMC Vet Res       Date:  2022-01-03       Impact factor: 2.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.